×
+ All Categories
Log in
English
Français
Español
Deutsch
The top documents tagged [biologics price competition]
Home >
biologics price competition
Biosimilars usa
822 views
AXINN, VELTROP & HARKRIDER LLP © 2007 | AXINN, VELTROP & HARKRIDER LLP Click To Modify Title Name Goes Here FDA Hearings on the BPCI Act.
213 views
Pharma and Biotech Industry Outlook - A look at trends and opportunities in this increasingly challenging environment with a focus on the generics landscape
3.804 views
E NGEL & N OVITT, LLP T HE L AW F IRM T HAT K NOWS I TS S CIENCE © E&N LLP US Regulatory Pathway For Biosimilars Practical Legal/Regulatory Considerations.
215 views
1 CBER Rare Diseases Program - Update 2011-2012 Nisha Jain, MD Chief, Clinical Review Branch DH/OBRR/CBER/FDA May 15, 2012 NORD Corporate Council.
216 views
New York Washington Seattle Brian J. Malkin, Partner (
[email protected]
) Brian J. Malkin, Partner (
[email protected]
)
[email protected]
Frommer Lawrence.
221 views
A New Pathway for Follow-on Biologics Presented by: Steve Nash
[email protected]
May 7, 2010.
214 views
1 Kansas Bio “Hot Topics In Science” April 1, 2010 “Key Life Science Provisions of the Healthcare Act of 2010”
216 views
Why aren’t Biosimilars Generics – Regulatory Challenges Adam Sabouni, PhD PharmaConsultz 4 th International Conference on Pharmaceutical Regulatory Affairs.
217 views
Safe Substitution of Biologics
69 views
Biosimilars webinar April 2015
259 views
1 AbbVie, Inc. Date: 12 November 2013 Jing Chen Hisham Haider Dewan Harout Sahakian.
216 views